表紙:自己免疫疾患診断の世界市場:2021年~2025年
市場調査レポート
商品コード
1018523

自己免疫疾患診断の世界市場:2021年~2025年

Global Autoimmune Disease Diagnostics Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
自己免疫疾患診断の世界市場:2021年~2025年
出版日: 2021年06月08日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の自己免疫疾患診断の市場規模は、2021年から2025年の間に19億8000万米ドル成長し、予測期間中は9%のCAGRで成長する見込みです。

同市場は、M&Aの増加、自己免疫診断の改善につながる新しいバイオマーカーの発見、およびラボラトリーオートメーションプラットフォームの進歩によって推進されています。

当レポートでは自己免疫疾患診断の世界市場の全体的な分析、市場規模と予測、動向、成長要因、課題、および約25のベンダーをカバーする分析を提供しています。

目次

エグゼクティブサマリー

市場情勢

  • 市場のエコシステム
  • バリューチェーン分析

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2020年の市場規模
  • 市場の見通し:2020年から2025年の予測

ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

市場セグメンテーション:製品別

  • 市場セグメンテーション
  • 製品別の比較
  • アッセイキット:市場規模と予測(2020年~2025年)
  • アナライザー:市場規模と予測(2020年~2025年)
  • 製品別の市場機会

市場セグメンテーション:タイプ別

  • 市場セグメンテーション
  • タイプ別の比較
  • 限局性自己免疫疾患診断:市場規模と予測(2020年~2025年)
  • 全身性自己免疫疾患診断:市場規模と予測(2020年~2025年)
  • タイプ別の市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2020年~2025年)
  • 欧州:市場規模と予測(2020年~2025年)
  • アジア:市場規模と予測(2020年~2025年)
  • その他の地域:市場規模と予測(2020年~2025年)
  • 主要国
  • 地域の市場機会
  • 市場の推進力
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hemagen Diagnostics Inc.
  • HOB Biotech Group Corp.
  • Quest Diagnostics Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR41431

Technavio has been monitoring the autoimmune disease diagnostics market and it is poised to grow by $ 1.98 bn during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing M&A, discovery of novel biomarkers leading to improved autoimmune diagnosis, and advancements in laboratory automation platforms. In addition, increasing M&A is anticipated to boost the growth of the market as well.

The autoimmune disease diagnostics market analysis includes product segment, type segment, and geographic landscape.

Technavio's autoimmune disease diagnostics market is segmented as below:

By Product

  • Assay kits
  • Analyzers

By Type

  • Localized autoimmune disease diagnostics
  • Systemic autoimmune disease diagnostics

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing consumer shift toward direct-to-consumer testing as one of the prime reasons driving the autoimmune disease diagnostics market growth during the next few years. Also, focus on companion diagnostic tests and shift from monoplex to multiplex testing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on autoimmune disease diagnostics market covers the following areas:

  • Autoimmune disease diagnostics market sizing
  • Autoimmune disease diagnostics market forecast
  • Autoimmune disease diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune disease diagnostics market vendors that include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc. Also, the autoimmune disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Assay kits - Market size and forecast 2020-2025
    • Analyzers - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Market Segmentation by Type
    • Market segments
    • Comparison by Type
    • Localized autoimmune disease diagnostics - Market size and forecast 2020-2025
    • Systemic autoimmune disease diagnostics - Market size and forecast 2020-2025
    • Market opportunity by Type
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corp.
    • F. Hoffmann-La Roche Ltd.
    • Hemagen Diagnostics Inc.
    • HOB Biotech Group Corp.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2020 - 2025 ($ million)
  • 14: Global market: Year-over-year growth 2020 - 2025 (%)
  • 15: Five forces analysis 2020 & 2025
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2020
  • 22: Product - Market share 2020-2025 (%)
  • 23: Comparison by Product
  • 24: Assay kits - Market size and forecast 2020-2025 ($ million)
  • 25: Assay kits - Year-over-year growth 2020-2025 (%)
  • 26: Analyzers - Market size and forecast 2020-2025 ($ million)
  • 27: Analyzers - Year-over-year growth 2020-2025 (%)
  • 28: Market opportunity by Product
  • 29: Type - Market share 2020-2025 (%)
  • 30: Comparison by Type
  • 31: Localized autoimmune disease diagnostics - Market size and forecast 2020-2025 ($ million)
  • 32: Localized autoimmune disease diagnostics - Year-over-year growth 2020-2025 (%)
  • 33: Systemic autoimmune disease diagnostics - Market size and forecast 2020-2025 ($ million)
  • 34: Systemic autoimmune disease diagnostics - Year-over-year growth 2020-2025 (%)
  • 35: Market opportunity by Type
  • 36: Customer landscape
  • 37: Market share by geography 2020-2025 (%)
  • 38: Geographic comparison
  • 39: North America - Market size and forecast 2020-2025 ($ million)
  • 40: North America - Year-over-year growth 2020-2025 (%)
  • 41: Europe - Market size and forecast 2020-2025 ($ million)
  • 42: Europe - Year-over-year growth 2020-2025 (%)
  • 43: Asia - Market size and forecast 2020-2025 ($ million)
  • 44: Asia - Year-over-year growth 2020-2025 (%)
  • 45: ROW - Market size and forecast 2020-2025 ($ million)
  • 46: ROW - Year-over-year growth 2020-2025 (%)
  • 47: Key leading countries
  • 48: Market opportunity by geography ($ million)
  • 49: Impact of drivers and challenges
  • 50: Vendor landscape
  • 51: Landscape disruption
  • 52: Industry risks
  • 53: Vendors covered
  • 54: Market positioning of vendors
  • 55: Abbott Laboratories - Overview
  • 56: Abbott Laboratories - Business segments
  • 57: Abbott Laboratories - Key offerings
  • 58: Abbott Laboratories - Key customers
  • 59: Abbott Laboratories - Segment focus
  • 60: bioMerieux SA - Overview
  • 61: bioMerieux SA - Business segments
  • 62: bioMerieux SA - Key offerings
  • 63: bioMerieux SA - Key customers
  • 64: bioMerieux SA - Segment focus
  • 65: Bio-Rad Laboratories Inc. - Overview
  • 66: Bio-Rad Laboratories Inc. - Business segments
  • 67: Bio-Rad Laboratories Inc. - Key offerings
  • 68: Bio-Rad Laboratories Inc. - Key customers
  • 69: Bio-Rad Laboratories Inc. - Segment focus
  • 70: Danaher Corp. - Overview
  • 71: Danaher Corp. - Business segments
  • 72: Danaher Corp. - Key offerings
  • 73: Danaher Corp. - Key customers
  • 74: Danaher Corp. - Segment focus
  • 75: F. Hoffmann-La Roche Ltd. - Overview
  • 76: F. Hoffmann-La Roche Ltd. - Business segments
  • 77: F. Hoffmann-La Roche Ltd. - Key offerings
  • 78: F. Hoffmann-La Roche Ltd. - Key customers
  • 79: F. Hoffmann-La Roche Ltd. - Segment focus
  • 80: Hemagen Diagnostics Inc. - Overview
  • 81: Hemagen Diagnostics Inc. - Product and service
  • 82: Hemagen Diagnostics Inc. - Key offerings
  • 83: Hemagen Diagnostics Inc. - Key customers
  • 84: Hemagen Diagnostics Inc. - Segment focus
  • 85: HOB Biotech Group Corp. - Overview
  • 86: HOB Biotech Group Corp. - Product and service
  • 87: HOB Biotech Group Corp. - Key offerings
  • 88: HOB Biotech Group Corp. - Key customers
  • 89: HOB Biotech Group Corp. - Segment focus
  • 90: Quest Diagnostics Inc. - Overview
  • 91: Quest Diagnostics Inc. - Business segments
  • 92: Quest Diagnostics Inc. - Key offerings
  • 93: Quest Diagnostics Inc. - Key customers
  • 94: Quest Diagnostics Inc. - Segment focus
  • 95: Siemens AG - Overview
  • 96: Siemens AG - Business segments
  • 97: Siemens AG - Key offerings
  • 98: Siemens AG - Key customers
  • 99: Siemens AG - Segment focus
  • 100: Thermo Fisher Scientific Inc. - Overview
  • 101: Thermo Fisher Scientific Inc. - Business segments
  • 102: Thermo Fisher Scientific Inc. - Key offerings
  • 103: Thermo Fisher Scientific Inc. - Key customers
  • 104: Thermo Fisher Scientific Inc. - Segment focus
  • 105: Currency conversion rates for US$
  • 106: Research Methodology
  • 107: Validation techniques employed for market sizing
  • 108: Information sources
  • 109: List of abbreviations